Pulse Biosciences Stock Buy Hold or Sell Recommendation
| PLSE Stock | USD 19.63 1.84 10.34% |
Given the investment horizon of 90 days and your highly speculative risk level, our recommendation regarding Pulse Biosciences is 'Strong Hold'. Macroaxis provides Pulse Biosciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding PLSE positions.
Check out Pulse Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Pulse Stock refer to our How to Trade Pulse Stock guide. Note, we conduct extensive research on individual companies such as Pulse and provide practical buy, sell, or hold advice based on investors' constraints. Pulse Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
Pulse |
Execute Pulse Biosciences Buy or Sell Advice
The Pulse recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Pulse Biosciences. Macroaxis does not own or have any residual interests in Pulse Biosciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Pulse Biosciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Modest | Details | |
Volatility | Moderately volatile | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Sell | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Pulse Biosciences Trading Alerts and Improvement Suggestions
| Pulse Biosciences had very high historical volatility over the last 90 days | |
| Net Loss for the year was (42.21 M) with loss before overhead, payroll, taxes, and interest of (550 K). | |
| Pulse Biosciences currently holds about 14.8 M in cash with (33.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.4. | |
| Pulse Biosciences has a poor financial position based on the latest SEC disclosures | |
| Roughly 72.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants |
Pulse Biosciences current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Pulse analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Pulse analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Pulse Biosciences Returns Distribution Density
The distribution of Pulse Biosciences' historical returns is an attempt to chart the uncertainty of Pulse Biosciences' future price movements. The chart of the probability distribution of Pulse Biosciences daily returns describes the distribution of returns around its average expected value. We use Pulse Biosciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Pulse Biosciences returns is essential to provide solid investment advice for Pulse Biosciences.
| Mean Return | 0.39 | Value At Risk | -5.54 | Potential Upside | 9.68 | Standard Deviation | 5.23 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Pulse Biosciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Pulse Stock Institutional Investors
| Shares | Westside Investment Management, Inc. | 2024-09-30 | 55 K | Bank Of New York Mellon Corp | 2024-09-30 | 40.3 K | Spotlight Asset Group, Inc. | 2024-06-30 | 40.3 K | Swiss National Bank | 2024-09-30 | 35.9 K | Goldman Sachs Group Inc | 2024-09-30 | 35.7 K | Ubs Asset Mgmt Americas Inc | 2024-09-30 | 33.5 K | Barclays Plc | 2024-09-30 | 30.3 K | Tiaa Trust National Association | 2024-09-30 | 27.3 K | Rhumbline Advisers | 2024-09-30 | 25.8 K | Blackrock Inc | 2024-06-30 | 1.1 M | Vanguard Group Inc | 2024-09-30 | 995.8 K |
Pulse Biosciences Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Investments | 10.5M | 7.6M | (401K) | (119K) | (136.9K) | (143.7K) | |
| Change In Cash | 5.6M | 16.2M | 32.5M | (16.8M) | (19.3M) | (18.3M) | |
| Free Cash Flow | (35.8M) | (54.5M) | (47.4M) | (33.2M) | (29.8M) | (31.3M) | |
| Depreciation | 1.1M | 1.1M | 1.4M | 1.2M | 1.4M | 1.1M | |
| Other Non Cash Items | (521K) | 116K | 13K | 8.7M | 15.0K | 14.2K | |
| Capital Expenditures | 441K | 437K | 401K | 121K | 108.9K | 103.5K | |
| Net Income | (49.9M) | (63.7M) | (58.5M) | (42.2M) | (38.0M) | (39.9M) | |
| End Period Cash Flow | 12.5M | 28.6M | 61.1M | 44.4M | 51.0M | 53.6M | |
| Change To Netincome | 12.4M | 11.3M | 10.2M | 14.6M | 16.8M | 17.6M |
Pulse Biosciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Pulse Biosciences or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Pulse Biosciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Pulse stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.37 | |
β | Beta against Dow Jones | 1.43 | |
σ | Overall volatility | 5.38 | |
Ir | Information ratio | 0.07 |
Pulse Biosciences Volatility Alert
Pulse Biosciences exhibits above-average semi-deviation for your current time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Pulse Biosciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Pulse Biosciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Pulse Biosciences Fundamentals Vs Peers
Comparing Pulse Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Pulse Biosciences' direct or indirect competition across all of the common fundamentals between Pulse Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Pulse Biosciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Pulse Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Pulse Biosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Pulse Biosciences to competition |
| Fundamentals | Pulse Biosciences | Peer Average |
| Return On Equity | -0.7 | -0.31 |
| Return On Asset | -0.38 | -0.14 |
| Current Valuation | 1.02 B | 16.62 B |
| Shares Outstanding | 61.52 M | 571.82 M |
| Shares Owned By Insiders | 71.93 % | 10.09 % |
| Shares Owned By Institutions | 9.31 % | 39.21 % |
| Number Of Shares Shorted | 2.17 M | 4.71 M |
| Price To Earning | (22.54) X | 28.72 X |
| Price To Book | 15.26 X | 9.51 X |
| Price To Sales | 60.23 X | 11.42 X |
| Revenue | (9 K) | 9.43 B |
| Gross Profit | (550 K) | 27.38 B |
| EBITDA | (42.37 M) | 3.9 B |
| Net Income | (42.21 M) | 570.98 M |
| Cash And Equivalents | 14.8 M | 2.7 B |
| Cash Per Share | 0.40 X | 5.01 X |
| Total Debt | 9.14 M | 5.32 B |
| Debt To Equity | 0.45 % | 48.70 % |
| Current Ratio | 3.14 X | 2.16 X |
| Book Value Per Share | 1.29 X | 1.93 K |
| Cash Flow From Operations | (33.04 M) | 971.22 M |
| Short Ratio | 21.18 X | 4.00 X |
| Earnings Per Share | (0.82) X | 3.12 X |
| Target Price | 5.0 | |
| Number Of Employees | 56 | 18.84 K |
| Beta | 1.75 | -0.15 |
| Market Capitalization | 992.88 M | 19.03 B |
| Total Asset | 59.15 M | 29.47 B |
| Retained Earnings | (336.92 M) | 9.33 B |
| Working Capital | 38.62 M | 1.48 B |
| Current Asset | 4 M | 9.34 B |
| Current Liabilities | 660 K | 7.9 B |
| Net Asset | 59.15 M |
Note: Disposition of 24656 shares by Robert Duggan of Pulse Biosciences at 11.0 subject to Rule 16b-3 [view details]
Pulse Biosciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Pulse . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 11774.97 | |||
| Daily Balance Of Power | 1.076023 | |||
| Rate Of Daily Change | 1.1 | |||
| Day Median Price | 18.93 | |||
| Day Typical Price | 19.16 | |||
| Price Action Indicator | 1.62 | |||
| Period Momentum Indicator | 1.84 |
About Pulse Biosciences Buy or Sell Advice
When is the right time to buy or sell Pulse Biosciences? Buying financial instruments such as Pulse Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Pulse Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Volatility ETFs Thematic Idea Now
Volatility ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Volatility ETFs theme has 26 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Volatility ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Pulse Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Pulse Stock refer to our How to Trade Pulse Stock guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulse Biosciences. If investors know Pulse will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulse Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pulse Biosciences is measured differently than its book value, which is the value of Pulse that is recorded on the company's balance sheet. Investors also form their own opinion of Pulse Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pulse Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulse Biosciences' market value can be influenced by many factors that don't directly affect Pulse Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulse Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulse Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulse Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.